BamSEC and AlphaSense Join Forces
Learn More

Horizon Pharmaceutical LLC

Formerly NASDAQ: RPTP

Material Contracts Filter

EX-10.1
from 8-K 6 pages Note Redemption Agreement
12/34/56
EX-10.1
from 8-K 11 pages Tender and Support Agreement
12/34/56
EX-10.29
from 10-K 6 pages Raptor Pharmaceutical Corp. 2010 Stock Incentive Plan 2016 Restricted Share Unit Award Agreement
12/34/56
EX-10.1
from 8-K 14 pages Raptor Pharmaceutical Corp. Form of Change in Control Severance Agreement
12/34/56
EX-10.1
from 10-Q 12 pages Executive Employment Agreement
12/34/56
EX-10.4
from 8-K 8 pages Execution Version Amendment No. 1 to the Development and License Agreement
12/34/56
EX-10.3
from 8-K 5 pages Letter Agreement
12/34/56
EX-10.2
from 8-K 41 pages Commercial Supply Agreement
12/34/56
EX-10.1
from 8-K 66 pages Development and License Agreement
12/34/56
EX-10.1
from 8-K 15 pages Transition and Separation Agreement
12/34/56
EX-10.3
from 10-Q 7 pages Raptor Pharmaceutical Corp. 2010 Stock Incentive Plan 2015 Restricted Share Unit Award Agreement
12/34/56
EX-10.50
from 10-K 4 pages Fourth Amendment to License Agreement Uc Control Number 2008-03-0236, Effective October 31, 2007 Between Raptor Pharmaceuticals, Inc. and the Regents of the University of California For: Case No. Sd2006-092: “Enterically Coated Cysteamine”
12/34/56
EX-10.49
from 10-K 4 pages Third Amendment to License Agreement Uc Control Number 2008-03-0236, Effective October 31, 2007 Between Raptor Therapeutics, Inc. and the Regents of the University of California For: Case No. Sd2006-092: “Enterically Coated Cysteamine”
12/34/56
EX-10.48
from 10-K 12 pages Executive Employment Agreement
12/34/56
EX-10.47
from 10-K 12 pages Executive Employment Agreement
12/34/56
EX-10.46
from 10-K 9 pages Raptor Pharmaceutical Corp. 2014 Employment Commencement Stock Incentive Plan Award Agreement
12/34/56
EX-10.45
from 10-K 19 pages Raptor Pharmaceutical Corp. 2014 Employment Commencement Stock Incentive Plan Plan Document
12/34/56
EX-10.1
from 8-K 12 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 10 pages Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K 38 pages Raptor Pharmaceutical Corp. $100,000,000 Second Amended and Restated Sales Agreement
12/34/56